Reviva Pharmaceuticals Holdings RVPH Income Statement (2018-2026)

OTC RVPH
$0.49 -0.01 (-2.00%)
At close: Aug 20, 2026 · 4:00 PM EDT
Income Statement May2018 Aug2018 Nov2018 Feb2019 May2019 Aug2019 Nov2019 Feb2020 May2020 Aug2020 Nov2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Shares Outstanding (Entity) (Quarter)
0.92M0.74M0.76M0.76M1.02M1.02M1.02M1.13M1.13M1.40M1.40M1.49M1.67M1.66M2.34M2.49M3.63M3.63M7.02M13.11M
Operating items
Research & Development (Quarter)
1.42M2.66M5.83M4.51M4.24M7.42M5.48M8.26M9.57M8.11M5.78M5.58M6.86M4.68M4.11M3.72M2.13M1.74M1.44M1.39M
Selling, General & Administrative (Quarter)
1.05M1.30M1.62M1.01M1.26M1.48M1.50M3.08M1.99M1.51M2.14M2.55M1.60M1.60M2.42M2.35M1.90M1.82M1.84M1.22M
Other Operating Expenses (Quarter)
Operating Expenses (Quarter)
2.48M3.96M7.45M5.52M5.50M8.89M6.98M11.34M11.56M9.62M7.92M8.13M8.46M6.28M6.54M6.07M4.03M3.56M3.27M2.62M
Operating Income (Quarter)
-2.48M-3.96M-7.45M-5.52M-5.50M-8.89M-6.98M-11.34M-11.56M-9.62M-7.92M-8.13M-8.46M-6.28M-6.54M-6.07M-4.03M-3.56M-3.27M-2.62M
EBIT (Quarter)
-2.48M-3.96M-7.45M-5.52M-5.50M-8.89M-6.98M-11.34M-11.56M-9.62M-7.92M-8.13M-8.46M-6.28M-6.54M-6.07M-4.03M-3.56M-3.27M-2.62M
Non-operating items
Non Operating Investment Income (Quarter)
Interest & Investment Income (Quarter)
-547.000.00M0.00M0.01M0.05M0.11M0.15M0.10M0.09M0.06M0.17M0.09M0.05M0.05M0.09M0.02M0.06M0.14M0.09M0.18M
Other Non Operating Income (Quarter)
0.20M0.28M0.09M0.18M0.02M0.01M-19.000.14M0.02M-0.13M0.20M-0.02M-0.67M-0.03M0.01M-0.01M809.00-0.00M-0.00M
Non Operating Income (Quarter)
0.20M0.28M0.09M0.19M0.05M-0.34M0.14M-0.37M0.23M0.26M0.50M0.28M0.10M0.03M0.11M0.03M0.02M0.19M0.08M0.17M
Net income details
EBT (Quarter)
-2.28M-3.68M-7.36M-5.33M-3.51M-12.03M-6.85M-11.70M-11.33M-9.42M-7.43M-7.85M-8.37M23.59M-6.43M-6.05M-4.01M-3.45M-3.19M-2.45M
Tax Provisions (Quarter)
0.00M0.00M0.01M0.00M-0.01M0.00M0.01M0.01M-0.11M0.01M0.01M0.00M0.01M0.01M0.00M-0.01M0.00M0.00M
Profit After Tax (Quarter)
-2.30M-3.72M-7.37M-5.30M-5.45M-9.28M-6.90M-11.70M-11.35M-9.39M-7.40M-7.90M-8.40M-6.22M-6.40M-6.10M-4.00M-3.40M-3.20M-2.45M
Income from Continuing Operations (Quarter)
-2.28M-3.68M-7.37M-5.34M-3.52M-12.02M-6.85M-11.71M-11.35M-9.30M-7.43M-7.86M-8.37M23.59M-6.43M-6.05M-4.01M-3.44M-3.20M-2.45M
Consolidated Net Income (Quarter)
-2.28M-3.68M-7.37M-5.34M-3.52M-12.02M-6.85M-11.71M-11.35M-9.30M-7.43M-7.86M-8.37M23.59M-6.43M-6.05M-4.01M-3.44M-3.20M-2.45M
Income towards Parent Company (Quarter)
-2.28M-3.68M-7.37M-5.34M-3.52M-12.02M-6.85M-11.71M-11.35M-9.30M-7.43M-7.86M-8.37M23.59M-6.43M-6.05M-4.01M-3.44M-3.20M-2.45M
Preferred Dividend Payments (Quarter)
Net Income towards Common Stockholders (Quarter)
-2.28M-3.68M-7.37M-5.34M-3.52M-12.02M-6.85M-11.71M-11.35M-9.30M-7.43M-7.86M-8.37M23.59M-6.43M-6.05M-4.01M-3.44M-3.20M-2.45M
Additional items
EPS (Basic) (Quarter)
-2.47-4.98-7.98-5.78-3.65-12.32-6.28-10.44-9.44-7.82-4.97-5.14-4.9514.23-2.64-2.43-1.10-0.95-0.46-0.35
Shares Outstanding (Quarter)
0.92M0.74M0.92M0.92M0.96M0.98M1.09M1.12M1.20M1.19M1.49M1.53M1.69M1.66M2.43M2.49M3.63M3.63M7.02M7.02M
EBITDA (Quarter)
-2.48M-3.96M-7.45M-5.52M-5.50M-8.89M-6.98M-11.34M-11.56M-9.62M-7.92M-8.13M-8.46M-6.28M-6.54M-6.07M-4.03M-3.56M-3.27M-2.62M
Interest Expenses (Quarter)
0.01M0.31M0.31M0.01M0.02M0.01M0.08M0.00M0.01M0.00M0.00M-0.01M0.01M0.00M
Tax Rate (Quarter)
-0.09-0.05-0.13-0.050.07-0.04-0.06-0.111.20-0.10-0.090.02-0.08-0.13-0.070.42-0.10-0.11